Soleus Capital Management, L.P.
CIK: 0001802630Latest portfolio: $2.7B · Q4 2025
Holdings
95
Total Value
$2.7B
New Positions
32
Closed Positions
25
Top Holdings
View All 95 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | XBISPDR SERIES TRUST | 2,900,000 | $353.6M | 13.04% | +1.8M | Put |
| 2 | KRYSKRYSTAL BIOTECH INC | 941,059 | $232.0M | 8.56% | -77,772 | |
| 3 | CELCCELCUITY INC | 1,808,258 | $180.4M | 6.65% | +629K | |
| 4 | NVCRNOVOCURE LTD | 8,530,665 | $110.3M | 4.07% | -1,114,207 | |
| 5 | PRAXPRAXIS PRECISION MEDICINES I | 362,966 | $107.0M | 3.95% | -496,200 | |
| 6 | TGTXTG THERAPEUTICS INC | 3,139,312 | $93.6M | 3.45% | -705,419 | |
| 7 | DC4DEXCOM INC | 1,297,094 | $86.1M | 3.18% | NEW | |
| 8 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,320,000 | $78.4M | 2.89% | +430K | |
| 9 | GMEDGLOBUS MED INC | 887,000 | $77.4M | 2.86% | +711K | |
| 10 | BBNXBETA BIONICS INC | 2,534,565 | $77.2M | 2.85% | -1,335,593 | |
| 11 | AM6AMICUS THERAPEUTICS INC | 5,207,284 | $74.2M | 2.74% | +517K | |
| 12 | TWSTTWIST BIOSCIENCE CORP | 1,861,802 | $59.1M | 2.18% | -4,432 | |
| 13 | ORGOORGANOGENESIS HLDGS INC | 9,985,951 | $51.7M | 1.91% | -2,145,748 | |
| 14 | SNDXSYNDAX PHARMACEUTICALS INC | 2,247,110 | $47.2M | 1.74% | +235K | |
| 15 | MIRMMIRUM PHARMACEUTICALS INC | 573,614 | $45.3M | 1.67% | +425K | |
| 16 | PODDINSULET CORP | 150,000 | $42.6M | 1.57% | NEW | |
| 17 | NPCENEUROPACE INC | 2,703,208 | $41.7M | 1.54% | -254,749 | |
| 18 | AXGNAXOGEN INC | 1,206,855 | $39.5M | 1.46% | -519,698 | |
| 19 | BSFAANI PHARMACEUTICALS INC | 486,243 | $38.4M | 1.42% | +146K | |
| 20 | ALKSALKERMES PLC | 1,322,364 | $37.0M | 1.36% | NEW | |
| 21 | LIVNLIVANOVA PLC | 567,500 | $34.9M | 1.29% | NEW | |
| 22 | GSKGSK PLC | 639,000 | $31.3M | 1.16% | +419K | |
| 23 | GONGERON CORP | 23,290,000 | $30.7M | 1.13% | +6.0M | |
| 24 | UTHUNITED THERAPEUTICS CORP DEL | 60,000 | $29.2M | 1.08% | -90,000 | |
| 25 | IMVTIMMUNOVANT INC | 1,110,000 | $28.2M | 1.04% | NEW |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Unknown0.0% ($8.608874151383842e+37T)
Financial Services0.0% ($353.6M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 12, 2026 | $2.7B | 95 |
| Q3 2025 | Nov 14, 2025 | $2.0T | 88 |
| Q2 2025 | Aug 15, 2025 | $1.5T | 95 |
| Q1 2025 | May 15, 2025 | $1.4T | 75 |
| Q4 2024 | Feb 14, 2025 | $1.6T | 81 |
| Q3 2024 | Nov 14, 2024 | $1291.5T | 87 |
| Q2 2024 | Aug 14, 2024 | $1134.0T | 92 |
| Q1 2024 | May 15, 2024 | $1347.4T | 91 |
| Q4 2023 | Feb 14, 2024 | $901.2T | 73 |
| Q3 2023 | Nov 14, 2023 | $1083.9T | 91 |
| Q2 2023 | Aug 14, 2023 | $899.5T | 101 |
| Q1 2023 | May 15, 2023 | $965.7T | 77 |
| Q4 2022 | Feb 14, 2023 | $697.1T | 72 |
| Q3 2022 | Nov 14, 2022 | $736.0B | 76 |
| Q2 2022 | Aug 15, 2022 | $641.0B | 72 |
| Q1 2022 | May 16, 2022 | $775.1B | 65 |
| Q4 2021 | Feb 14, 2022 | $998.8B | 68 |
| Q3 2021 | Nov 15, 2021 | $641.7B | 72 |
| Q2 2021 | Aug 16, 2021 | $650.3B | 65 |
| Q1 2021 | May 17, 2021 | $555.0B | 72 |
| Q4 2020 | Feb 16, 2021 | $660.6B | 65 |
| Q3 2020 | Nov 13, 2020 | $188.6B | 63 |
| Q2 2020 | Aug 14, 2020 | $175.4B | 61 |
| Q1 2020 | May 15, 2020 | $85.9B | 48 |
| Q4 2019 | Feb 14, 2020 | $103.7B | 49 |
Fund Information
Soleus Capital Management, L.P. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $2.7B across 95 holdings. The largest position is SPDR SERIES TRUST (XBI), representing 13.0% of the portfolio. Compared to the previous quarter, the fund opened 32 new positions and closed 25 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.